EEB 180: Genetic Engineering in Developing Countries


The Cartagena Protocol and GM mosquitoes


Contents


Background

 

GM mosquitoes as LMOs


GM mosquitoes are included within the scope of the Cartagena Protocol:

 

GM mosquitoes in transit


GM mosquitoes in transit are not covered by the Cartagena Protocol:

 

GM mosquitoes in contained field trials


GM mosquitoes in contained field trials are not covered by the Advance Informed Agreement:

 

First intentional environmental release of GM mosquitoes


The Advance Informed Agreement does cover the first intentional environmental release of GM mosquitoes:

 

Secondary transboundary movements


The environmental release of a GM mosquito is essentially a global release:

What does the Cartagena Protocol have to say about transboundary movements?

What does the Protocol say if an unintentional transboundary movement does occur?

 

Regional arrangements


Could regional arrangements provide a solution?

 

GM mosquitoes as pharmaceuticals


Could GM mosquitoes be exempt from the Cartagena Protocol because they are seen as pharmaceuticals?

 

Implications of the US not signing the Protocol


Institutions in the US are very involved in the creation of transgenic mosquitoes for disease control:

But the US are not a signatory to the Cartagena Protocol:

What can be done?

 

References